Average Insider

Where insiders trade, we follow

$MAIA
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Healthcare
Sector
Biotechnology
Industry
Vlad Vitoc
CEO
13
Employees
$1.30
Current Price
$77.03M
Market Cap
52W Low$0.87
Current$1.3018.5% above low, 81.5% below high
52W High$3.19

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys33$203,775.79149,700All Buys
Sells00--
2 weeksBuys33$203,775.79149,700All Buys
Sells00--
1 monthBuys33$203,775.79149,700All Buys
Sells00--
2 monthsBuys33$203,775.79149,700All Buys
Sells00--
3 monthsBuys33$203,775.79149,700All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jun 1, 2026
Vitoc Vlad
Director
Purchase72,700$1.39$100,885.79View Details
Jun 1, 2026
Smith Stan
Director
Purchase75,000$1.34$100,200.00View Details
Jun 1, 2026
Gryaznov Sergei
Chief Scientific Officer
Purchase2,000$1.34$2,690.00View Details
19 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Mar 20, 2026
EPS
Estimated-$0.13
Actual-$696.79
Miss
Revenue
EstimatedN/A
ActualN/A
2 more earnings records available โ€” create a free account to see 12 months of history

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.5.2